{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:43:14Z","timestamp":1792197794340,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ijantimicag.2023.106958","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T11:20:40Z","timestamp":1692876040000},"page":"106958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Association between vancomycin therapeutic drug monitoring and clinical outcomes in treating neonatal sepsis"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4268-0879","authenticated-orcid":false,"given":"Erin","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2023.106958_bib0001","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0002","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41390-021-01749-3","article-title":"Neonatal sepsis definitions from randomised clinical trials","volume":"93","author":"Hayes","year":"2023","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0003","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41390-020-0850-5","article-title":"Neonatal sepsis: need for consensus definition, collaboration and core outcomes","volume":"88","author":"Molloy","year":"2020","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0004","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2147\/CLEP.S72282","article-title":"Sepsis in Canadian children: a national analysis using administrative data","volume":"6","author":"Thompson","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S2213-2600(18)30063-8","article-title":"The global burden of paediatric and neonatal sepsis: a systematic review","volume":"6","author":"Fleischmann-Struzek","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0006","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/archdischild-2020-320217","article-title":"Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis","volume":"106","author":"Fleischmann","year":"2021","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0007","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0008","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/ANC.0000000000000769","article-title":"Neonatal Sepsis: A Review of Pathophysiology and Current Management Strategies","volume":"21","author":"Glaser","year":"2021","journal-title":"Adv Neonatal Care"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0009","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1128\/JCM.00967-10","article-title":"Coagulase-Negative Staphylococcal Skin Carriage among Neonatal Intensive Care Unit Personnel: from Population to Infection","volume":"48","author":"Hira","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0010","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/INF.0b013e318060cc03","article-title":"Clinical and molecular epidemiologic characteristics of coagulase-negative staphylococcal bloodstream infections in intensive care neonates","volume":"26","author":"Hira","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0011","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12887-018-1176-x","article-title":"Bacteriological profile and antibiotic susceptibility of neonatal sepsis in neonatal intensive care unit of a tertiary hospital in Nepal","volume":"18","author":"Pokhrel","year":"2018","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0012","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1875-9572(09)60042-5","article-title":"Neonatal sepsis: a 6-year analysis in a neonatal care unit in Taiwan","volume":"50","author":"Wu","year":"2009","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0013","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0014","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.tibtech.2020.03.001","article-title":"On-Site Therapeutic Drug Monitoring","volume":"38","author":"Ates","year":"2020","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0015","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/cid\/cir529","article-title":"Vancomycin Therapeutic Guidelines: Closer Examination of Neonatal Pharmacokinetics","volume":"53","author":"Croes","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0016","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/s13104-016-2252-7","article-title":"The safety and efficacy of high versus low vancomycin trough levels in the treatment of patients with infections caused by methicillin-resistant Staphylococcus aureus: a meta-analysis","volume":"9","author":"Tongsai","year":"2016","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0017","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijid.2019.12.036","article-title":"Correlation of the vancomycin 24-h area under the concentration-time curve (AUC24) and trough serum concentration in children with severe infection: A clinical pharmacokinetic study","volume":"92","author":"Issaranggoon na Ayuthaya","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0018","doi-asserted-by":"crossref","first-page":"S439","DOI":"10.1093\/ofid\/ofy210.1255","article-title":"Examining the Relationship Between Vancomycin Area Under the Concentration\u2013Time Curve and Serum Trough Levels in Adults with Presumed or Documented Staphylococcal Infections","volume":"5","author":"Clark","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0019","unstructured":"Vitros Chemistry Products VANC Reagent - Instructions for use. Version 12.1. p. 1\u201311."},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/tropej\/fml054","article-title":"Randomized Controlled Trial of 7-Day vs. 14-Day Antibiotics for Neonatal Sepsis","volume":"52","author":"Chowdhary","year":"2006","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0021","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1111\/j.1469-0691.2011.03489.x","article-title":"Clinical and microbiological profile of persistent coagulase-negative staphylococcal bacteraemia in neonates","volume":"17","author":"Dimitriou","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0022","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000514402","article-title":"Use of Composite Outcomes in Neonatal Trials: An Analysis of the Cochrane Reviews","volume":"118","author":"Lai","year":"2021","journal-title":"Neonatology"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0023","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MOP.0b013e32834f62d5","article-title":"Update on acute kidney injury in the neonate","volume":"24","author":"Jetton","year":"2012","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0024","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1093\/ndt\/gft074","article-title":"Neonatal RIFLE","volume":"28","author":"Ricci","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1067\/mpd.2001.109608","article-title":"SNAP-II and SNAPPE-II: Simplified newborn illness severity and mortality risk scores","volume":"138","author":"Richardson","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0026","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41372-019-0519-2","article-title":"Vancomycin drug monitoring in infants with CoNS sepsis-target attainment, microbiological response and nephrotoxicity","volume":"40","author":"Viel-Th\u00e9riault","year":"2020","journal-title":"J Perinatol"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0027","series-title":"Sample Size Calculations in Clinical Research","author":"Chow","year":"2008"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0028","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/EDE.0000000000000409","article-title":"Selection Bias Due to Loss to Follow Up in Cohort Studies","volume":"27","author":"Howe","year":"2016","journal-title":"Epidemiology"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0029","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/FTD.0000000000000986","article-title":"An Audit to Evaluate Vancomycin Therapeutic Drug Monitoring in a Neonatal Intensive Care Unit","volume":"44","author":"Alrahahleh","year":"2022","journal-title":"Ther Drug Monit"},{"issue":"2","key":"10.1016\/j.ijantimicag.2023.106958_bib0030","article-title":"Dosing of vancomycin and target attainment in neonates: a systematic review","volume":"59","author":"Alrahahleh","year":"2022","journal-title":"Int J AntimicrobAgents"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0031","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4212\/cjhp.v72i3.2901","article-title":"Assessment of empiric vancomycin regimen in the neonatal intensive care unit","volume":"72","author":"Ywaya","year":"2019","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0032","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01109-22","article-title":"Association between Vancomycin Pharmacokinetic Parameters and Clinical and Microbiological Efficacy in a Cohort of Neonatal Patients","volume":"66","author":"Mejias-Trueba","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0033","doi-asserted-by":"crossref","DOI":"10.1002\/phar.2865","article-title":"Using population pharmacokinetics to optimize initial vancomycin dosing guidelines for neonates to treat sepsis caused by coagulase-negative staphylococcus","author":"Chung","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0034","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/CLEP.S187381","article-title":"Inhospital death is a biased measure of fatal outcome from bloodstream infection","volume":"11","author":"Laupland","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0035","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s40262-021-01027-9","article-title":"Population Pharmacokinetic Models of Vancomycin in Paediatric Patients: A Systematic Review","volume":"60","author":"Chung","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0036","first-page":"13","volume":"13","author":"Rybak","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0037","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/phar.2722","article-title":"Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta-analysis","volume":"42","author":"Abdelmessih","year":"2022","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0038","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01568-12","article-title":"Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter","volume":"57","author":"van Hal","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0039","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1128\/AAC.03620-14","article-title":"Association between Vancomycin Trough Concentration and Area under the Concentration-Time Curve in Neonates","volume":"58","author":"Frymoyer","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0040","doi-asserted-by":"crossref","first-page":"e01647","DOI":"10.1128\/AAC.01647-17","article-title":"Evaluating the Relationship between Vancomycin Trough Concentration and 24-Hour Area under the Concentration-Time Curve in Neonates","volume":"62","author":"Tseng","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0041","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00067-19","article-title":"Revising Pediatric Vancomycin Dosing Accounting for Nephrotoxicity in a Pharmacokinetic-Pharmacodynamic Model","volume":"63","author":"Kloprogge","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0042","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.amjmed.2010.07.025","article-title":"Increasing Vancomycin Serum Trough Concentrations and Incidence of Nephrotoxicity","volume":"123","author":"Pritchard","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0043","doi-asserted-by":"crossref","DOI":"10.1186\/s12887-016-0753-0","article-title":"Coagulase negative staphylococcal sepsis in neonates: Do we need to adapt vancomycin dose or target?","volume":"16","author":"Padari","year":"2016","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0044","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41372-019-0519-2","article-title":"Vancomycin drug monitoring in infants with CoNS sepsis-target attainment, microbiological response and nephrotoxicity","volume":"40","author":"Viel-Theriault","year":"2020","journal-title":"J Perinatol"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106300","article-title":"Determination of vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing","volume":"57","author":"Tang","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.106958_bib0046","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S2352-4642(21)00305-9","article-title":"Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial","volume":"6","author":"Hill","year":"2022","journal-title":"Lancet Child Adolesc Health"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923002376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923002376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:47:44Z","timestamp":1760377664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857923002376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0924857923002376"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106958","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between vancomycin therapeutic drug monitoring and clinical outcomes in treating neonatal sepsis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106958"}}